These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7490821)

  • 1. The immunological features of Peyronie's disease.
    Ralph DJ; Mirakian R; Pryor JP; Bottazzo GF
    J Urol; 1996 Jan; 155(1):159-62. PubMed ID: 7490821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic fibroblast growth factor expression in Peyronie's disease.
    Mulhall JP; Thom J; Lubrano T; Shankey TV
    J Urol; 2001 Feb; 165(2):419-23. PubMed ID: 11176387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic findings in Peyronie's disease: a controlled study.
    Schiavino D; Sasso F; Nucera E; Alcini E; Gulino G; Milani A; Patriarca G
    Urology; 1997 Nov; 50(5):764-8. PubMed ID: 9372889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there an immunogenetic basis for Peyronie's disease?
    Leffell MS
    J Urol; 1997 Jan; 157(1):295-7. PubMed ID: 8976283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peyronie's disease is associated with an HLA class II antigen, HLA-DQ5, implying an autoimmune etiology.
    Nachtsheim DA; Rearden A
    J Urol; 1996 Oct; 156(4):1330-4. PubMed ID: 8808864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Peyronie's disease--a review.
    Tunuguntla HS
    World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective analysis of 16S rDNA as a highly sensitive marker for bacterial presence in Peyronie's disease plaques.
    Hauck EW; Domann E; Hauptmann A; Weidner W; Chakraborty T; Hossain HM
    J Urol; 2003 Nov; 170(5):2053-6. PubMed ID: 14532852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in the transforming growth factor (TGF)-beta pathway as a potential factor in the pathogenesis of Peyronie's disease.
    Haag SM; Hauck EW; Szardening-Kirchner C; Diemer T; Cha ES; Weidner W; Eickelberg O
    Eur Urol; 2007 Jan; 51(1):255-61. PubMed ID: 16782264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peyronie's disease: a review.
    Gholami SS; Gonzalez-Cadavid NF; Lin CS; Rajfer J; Lue TF
    J Urol; 2003 Apr; 169(4):1234-41. PubMed ID: 12629334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation increases fibrogenic cytokine expression by Peyronie's disease fibroblasts.
    Mulhall JP; Branch J; Lubrano T; Shankey TV
    J Urol; 2003 Jul; 170(1):281-4. PubMed ID: 12796706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Functional magnetic resonance of Peyronie's disease in the chronic stable phase].
    Tamburrini O; Della Sala M; Sessa M; Carallo OF; Imbimbo C; Mirone V; Morrone G
    Radiol Med; 1993 Dec; 86(6):851-5. PubMed ID: 8296007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of loss of penile rigidity associated with Peyronie's disease.
    Krane RJ
    Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plaque incision and grafting as a salvage after a failed Nesbit procedure for Peyronie's disease.
    Muneer A; Kalsi J; Christopher N; Minhas S; Ralph DJ
    BJU Int; 2004 Oct; 94(6):878-80. PubMed ID: 15476526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there any association between Peyronie's disease and serum collagen markers?
    Rhoden EL; Buselato LG; Ting HY; Telöken C; Souto CA
    Int J Impot Res; 2000 Dec; 12(6):302-4. PubMed ID: 11416832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lengthening shortened penis caused by Peyronie's disease using circular venous grafting and daily stretching with a vacuum erection device.
    Lue TF; El-Sakka AI
    J Urol; 1999 Apr; 161(4):1141-4. PubMed ID: 10081856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic and bacteriological aspects of Peyronie's disease.
    Ralph DJ; Schwartz G; Moore W; Pryor JP; Ebringer A; Bottazzo GF
    J Urol; 1997 Jan; 157(1):291-4. PubMed ID: 8976282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morphological characteristics of Peyronie's disease].
    Kapuller LL; Derevianko VP; Novak GIa; Bukhman AA
    Arkh Patol; 1982; 44(10):49-54. PubMed ID: 7181709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the paradigm for plaque development in Peyronie's disease.
    Mulhall JP
    Int J Impot Res; 2003 Oct; 15 Suppl 5():S93-102. PubMed ID: 14551585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie's disease.
    Kalsi J; Minhas S; Christopher N; Ralph D
    BJU Int; 2005 May; 95(7):1029-33. PubMed ID: 15839925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgical treatment of erectile dysfunction in Peyronie's disease].
    Tarasov NI; Bavil'skiĭ VF; Plaksin OF; Kondrat'ev LN
    Urologiia; 2001; (6):35-40. PubMed ID: 11785080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.